97 related articles for article (PubMed ID: 11424818)
1. [Use of recombinant human erythropoietin in newborns with very low weight: efficacy monitoring].
Bagna R; Borgione S; Garbarini S; Costa S; Bertino E; David O; Fabris C
Acta Biomed Ateneo Parmense; 2000; 71 Suppl 1():627-31. PubMed ID: 11424818
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study.
Shannon KM; Mentzer WC; Abels RI; Freeman P; Newton N; Thompson D; Sniderman S; Ballard R; Phibbs RH
J Pediatr; 1991 Jun; 118(6):949-55. PubMed ID: 2040933
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study.
Shannon KM; Mentzer WC; Abels RI; Wertz M; Thayer-Moriyama J; Li WY; Thompson D; Decelle S; Phibbs RH
J Pediatr; 1992 Apr; 120(4 Pt 1):586-92. PubMed ID: 1372652
[TBL] [Abstract][Full Text] [Related]
5. Early treatment of premature infants with recombinant human erythropoietin.
Messer J; Haddad J; Donato L; Astruc D; Matis J
Pediatrics; 1993 Oct; 92(4):519-23. PubMed ID: 8414820
[TBL] [Abstract][Full Text] [Related]
6. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.
Maier RF; Obladen M; Scigalla P; Linderkamp O; Duc G; Hieronimi G; Halliday HL; Versmold HT; Moriette G; Jorch G
N Engl J Med; 1994 Apr; 330(17):1173-8. PubMed ID: 8139627
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin in anemia of prematurity.
Whitehall JS; Patole SK; Campbell P
Indian Pediatr; 1999 Jan; 36(1):17-27. PubMed ID: 10709119
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin and prematurity--where do we stand?
Carbonell-Estrany X; Figueras-Aloy J; Alvarez E
J Perinat Med; 2005; 33(4):277-86. PubMed ID: 16207112
[TBL] [Abstract][Full Text] [Related]
9. [Randomized multi-center trial of the administration of erythropoietin in anemia of prematurity].
Javier Manchón G; Natal Pujol A; Coroleu Lletget W; Zuasnábar Cotro A; Badía Barnusell J; Juncá Piera J; Bel Comós J; Sábado Alvarez C; Prats Viñas J
An Esp Pediatr; 1997 Jun; 46(6):587-92. PubMed ID: 9297428
[TBL] [Abstract][Full Text] [Related]
10. High Prevalence of Iron Deficiency Despite Standardized High-Dose Iron Supplementation During Recombinant Erythropoietin Therapy in Extremely Low Gestational Age Newborns.
Siddappa AM; Olson RM; Spector M; Northrop E; Zamora T; Brearley AM; Georgieff MK; Rao R
J Pediatr; 2020 Jul; 222():98-105.e3. PubMed ID: 32418819
[TBL] [Abstract][Full Text] [Related]
11. Growth, efficacy, and safety of feeding an iron-fortified human milk fortifier.
Berseth CL; Van Aerde JE; Gross S; Stolz SI; Harris CL; Hansen JW
Pediatrics; 2004 Dec; 114(6):e699-706. PubMed ID: 15545616
[TBL] [Abstract][Full Text] [Related]
12. A management guideline to reduce the frequency of blood transfusion in very-low-birth-weight infants.
Rabe H; Alvarez JR; Lawn C; Seddon P; Amess PN
Am J Perinatol; 2009 Mar; 26(3):179-83. PubMed ID: 19085812
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study.
Meyer MP; Meyer JH; Commerford A; Hann FM; Sive AA; Moller G; Jacobs P; Malan AF
Pediatrics; 1994 Jun; 93(6 Pt 1):918-23. PubMed ID: 8190577
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human erythropoietin in the treatment of anemia of prematurity.
Chen JY; Wu TS; Chanlai SP
Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930
[TBL] [Abstract][Full Text] [Related]
15. [Criteria for diagnosis and therapy of hyporegeneratory anemia in premature newborns below 33 week of gestation and body weight below 1500 grams].
Pramatarova T; Vakrilova L; Slŭncheva B; Iarŭkova N; Kalaĭdzhieva M; Emilova Z; Shishkova R; Popivanova A; Zhekova N
Akush Ginekol (Sofiia); 2007; 46 Suppl 1():63-6. PubMed ID: 18173017
[TBL] [Abstract][Full Text] [Related]
16. [Usefulness of erythropoietin in the treatment of anemia of prematurity. Influence of birth weight].
Carbonell Estrany X; Figueras Aloy J; Pérez Fernández JM; Fernández López A; González Luis G; Salvía Roiges MD
An Esp Pediatr; 1999 Sep; 51(3):281-6. PubMed ID: 10575752
[TBL] [Abstract][Full Text] [Related]
17. Prediction of transfusions in extremely low-birthweight infants in the erythropoietin era.
Hosono S; Mugishima H; Shimada M; Minato M; Okada T; Takahashi S; Harada K
Pediatr Int; 2006 Dec; 48(6):572-6. PubMed ID: 17168976
[TBL] [Abstract][Full Text] [Related]
18. [Effects of recombinant human erythropoietin in the treatment of anemia of prematurity].
Rosati E; Latini G; De Mitri B; Quartulli L; Caliandro P
Pediatr Med Chir; 1995; 17(1):45-8. PubMed ID: 7739926
[TBL] [Abstract][Full Text] [Related]
19. Effect of beginning recombinant erythropoietin treatment within the first week of life, among very-low-birth-weight neonates, on "early" and "late" erythrocyte transfusions: a meta-analysis.
Kotto-Kome AC; Garcia MG; Calhoun DA; Christensen RD
J Perinatol; 2004 Jan; 24(1):24-9. PubMed ID: 14726934
[TBL] [Abstract][Full Text] [Related]
20. Effects of recombinant human erythropoietin in infants with very low birth weights.
Samanci N; Ovali F; Dagoglu
J Int Med Res; 1996; 24(2):190-8. PubMed ID: 8737229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]